Stock Taper
SCREENER COMPARE ANY 2 STOCKS
ALC
ALCON INC.
NYSE
$72.01
▼ DOWN 0.30% (-0.22)

KEY STATISTICS

Market Cap$35.12 B
52w High$87.64
52w Low$61.84
Dividend Yield0.55%
FrequencyAnnual
P/E22.64
Volume1.18M
Shares Out.487.70M

COMPANY

LEADERSHIP

David J. Endicott
CHIEF EXECUTIVE
David J. Endicott

ABOUT

SECTOR
Healthcare
WENT PUBLIC
April 9, 2019
METHOD OF GOING PUBLIC
N/A
FULL TIME EMPLOYEES
25,000

PRICE TARGET

Target High$85.00
Target Low$35.00
Target Median$79.00
Target Consensus$73.43

UPCOMING EARNINGS

DateNov 10, 2026
DayTuesday
Rev. Est.$2.76B
NOV
10
TUE

PRICE

$72.01 ▼ DOWN 0.30% (−$0.22)
$71.40$71.60$71.80$72.009:30 AM10:35 AM11:40 AM12:45 PM1:49 PM2:54 PM3:59 PM72.01

About Alcon Inc.

https://www.alcon.com ↗

Alcon Inc. is a global eye care leader developing and selling surgical, vision correction, and ocular health products, including IOLs, lasers, contact lenses, and eye medications, serving eye care professionals and patients worldwide.

INDUSTRY

Medical - Specialties

A PRODUCT ALCON INC. IS KNOWN FOR

TOTAL30 Multifocal for Astigmatism
TOTAL30 Multifocal for Astigmatism

Launched in February 2026, this first-of-its-kind monthly replacement multifocal toric contact lens with Water Gradient Technology provides comfortable, clear vision at all distances for patients with astigmatism and presbyopia.

COMPETITORS

COMPETITOR
BLCO COMPARE
COO COMPARE
GKOS COMPARE
JNJ COMPARE
STAA COMPARE

Revenue by Geography

MapREGIONQ2-2019Q2-2020Q2-2021Q4-2021
UNITED STATES— — $958M $2.69B ▲
International Geographic Areas— — $1.14B —
Foreign countries$1.08B $705M ▼— —
Country of domicile$779M $493M ▼— —

ETFS HOLDING THIS STOCK

ETFS HOLDING
35
LISTED HERE
20
RANKED BY POSITION SIZE
EQ
EQTY
3.06% · 495.2K
DFIV
0.16% · 489.5K
RU
RUNN
1.82% · 105.8K
JHMD
0.33% · 44.5K
PXF
0.10% · 39.9K
MVEE.F
1.53% · 12.9K
CACG
0.88% · 12.0K
DBLV
1.46% · 10.4K
NTSI
0.15% · 10.3K
YLDW
1.70% · 9.5K
DM
DMRI
0.20% · 5.2K
SHRT
0.56% · 998
ESIM
0.24% · 615
GEQ
0.02% · 595
SEPA.L
0.39% · 313
TACN
0.08% · 289
PXUS
0.03% · 48
VO
VOXP
0.05% · 39
UIW2.F
1.71% · 0
FTLS
-0.13% · -43.5K

INSTITUTIONAL OWNERSHIP

SHARES OWNED
28.80%
HOLDERS
974
TOP 12 OF 974 · RANKED BY POSITION SIZE
Vanguard Group Inc
21.5M sh · $1.7B
Bank Of New York Mellon Corp
15.7M sh · $1.18B
Credit Suisse AG/
15.5M sh · $1.29B
Fmr LLC
12.4M sh · $938.26M
Norges Bank
12.1M sh · $961.07M
Aristotle Capital Management, LLC
10.7M sh · $797.68M
Invesco Ltd.
10.4M sh · $696.52M
Price T Rowe Associates Inc /Md/
10.3M sh · $764.14M
Ako Capital Llp
9.7M sh · $651.94M
Zurcher Kantonalbank (Zurich Cantonalbank)
8.5M sh · $632.57M
Ubs Group AG
7.2M sh · $480.19M
Select Equity Group, L.P.
6.7M sh · $501.08M

RATINGS SNAPSHOT

Overall rating: B

DCFROEROAD/EP/EP/B
Discounted Cash Flow4
Return On Equity3
Return On Assets3
Debt To Equity2
Price To Earnings1
Price To Book3
Overall Score3

TRADES BY CONGRESS

HOUSE TRADES
Josh Gottheimer
Josh Gottheimer
Sale
2026-03-12
 Julie Johnson
Julie Johnson
Sale
2025-03-03
 Daniel Goldman
Daniel Goldman
Sale
2023-07-10
 Ro Khanna
Ro Khanna
Sale
2022-02-17

MOST RECENT ANALYST GRADES

GRADE SUMMARY
OUTPERFORM 2
BUY 2
OVERWEIGHT 2
NEUTRAL 1
EQUAL WEIGHT 1
HOLD 1
UNDERPERFORM 1
10 GRADES IN THE LAST 12 MONTHS
Mizuho OUTPERFORM JP Morgan NEUTRAL Needham BUY BTIG BUY Barclays EQUAL WEIGHT Baird OUTPERFORM Wells Fargo OVERWEIGHT Stifel HOLD

SECTORS PEERS

PEERPRICE
CAH$234.55COMPARE
BDX$189.52COMPARE
HUM$385.54COMPARE
A$153.85COMPARE
IQV$261.75COMPARE
RMD$240.33COMPARE
GEHC$71.72COMPARE
MTD$1398.58COMPARE